Cadrenal Therapeutics (CVKD) Net Equity Issued and Repurchased (2022 - 2026)
Cadrenal Therapeutics (CVKD) posted Net Equity Issued and Repurchased of $1.2 million for Q2 2026, down 11.9% from the prior quarter.
Powered by 
Analysis
Cadrenal Therapeutics (CVKD) Net Equity Issued and Repurchased (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Cadrenal Therapeutics was $4.08 million; for FY2025, it came in at $4.86 million, down 5.5% from FY2024.
- Annual Net Equity Issued and Repurchased shows a three-year compound annual growth rate of 748.8% (FY2022 to FY2025).
- In prior years, Cadrenal Therapeutics' Net Equity Issued and Repurchased was $5.14 million in FY2024 (-4.9%), $5.41 million in FY2023 and $7,950 in FY2022.
- Quarterly Net Equity Issued and Repurchased has run from a low of $298.00 in Q1 2024 to a high of $5.41 million in Q1 2023 over five years.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $1.37 million (Q1 2026), $846,108 (Q4 2025) and $667,980 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Cadrenal Therapeutics | 3.35 Mn | -9.27 Mn | - | 1.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 846,108.00 |
| Sep 30, 2025 | 667,980.00 |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 3.51 Mn |
| Sep 30, 2024 | 1.64 Mn |
| Mar 31, 2024 | 298.00 |
| Mar 31, 2023 | 5.41 Mn |
| Jun 30, 2022 | 450.00 |
| Mar 31, 2022 | 7,500.00 |
API Access
Cadrenal Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CVKD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "CVKD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=CVKD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();